CovidVax show full list


DIOSynVax + University of Cambridge + PharmaJet
vaccine type: DNA-based
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)
Oct 27CambridgeUni received a multi-million dollar funding for clinical trial using PharmaJet's needle-free system to deliver vaccine (by
Sep 17CambridgeUni's vaccine has shown excellent safety and immunogenicity in Phase 1-2 trials (by
Mar 17DIOSynVax's approach can lead to a vaccine candidate for human clinical trials in June (by
Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
currently no early development info

£1.9 million from UK government
Aug 26Cambridge's vaccine could start UK clinical trials in Q4 2020 thanks to a £1.9M award from UK govt (by
Aug 26CambridgeUni has received a £1.9m grant from the UK Gov to conduct clinical trials of its vaccine candidate (by

contact | about | ©2020 project